Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA514385 ID: 514385

Safety and Efficacy of Intravenous Norepinephrine for Orthostatic Hypotension - ARD 6104 (human)

See Genome Information for Homo sapiens
Patients with chronic autonomic failure (CAF) often have disabling orthostatic hypotension (OH). OH in CAF patients is often associated with supine hypertension (hypertension while lying down), which can be severe. Drugs to treat OH worsen supine hypertension. Therefore, the combination of OH with supine hypertension poses a difficult therapeutic challenge. This protocol is a first step toward development of a way to maintain blood pressure during standing without worsening hypertension while lying down. The research question is will a drug (norepinephrine) given intravenously (IV) prevent blood pressure from falling in patients with orthostatic hypotension. This is a placebo controlled, blinded study of 15 patients with neurogenic orthostatic hypotension. More...
AccessionPRJNA514385; dbGaP: phs001769
TypeUmbrella project (Subtype:Authorized Access)
OrganismHomo sapiens[Taxonomy ID: 9606]
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
SubmissionRegistration date: 10-Jan-2019
NCATS
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Genotype and Phenotype (dbGaP)1
Safety and Efficacy of Intravenous Norepinephrine for Orthostatic Hypotension - ARD 6104 encompasses the following sub-project:
Project TypeNumber of Projects
Phenotype or Genotype1
BioProject
accession
OrganismTitle
PRJNA514386Homo sapiensSafety and Efficacy of Intravenous Norepinephrine for Orthostatic Hypotension - ARD 6104 (Vanderbilt University Medical...)

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center